Showing results (101-110 of 468) with videos related to
Sort By:
Pageof 47
European Urology Focus|July 21, 2017
Smoking and Prostate Cancer: A Systematic ReviewCosimo De Nunzio, Gerald L Andriole, Ian M Thompson, et al.The Journal of Urology|January 10, 2004
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trialsCatherine M Tangen, Phyllis J Goodman, John J Crowley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Phase III prostate cancer prevention trials: are the costs justified?Ian M Thompson, Catherine M Tangen, Eric A Klein, et al.Urology|December 12, 2002
Questionnaire-based outcomes of urinary incontinence and satisfaction rates after radical prostatectomy in a national study populationMichael Sebesta, R Duane Cespedes, Eva Luhman, et al.Mini Reviews in Medicinal Chemistry|April 8, 2010
Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer managementAddanki P Kumar, Heather Graham, Craig Robson, et al.The Journal of Urology|October 16, 2007
Biomarkers for prostate cancer detectionDipen J Parekh, Donna Pauler Ankerst, Dean Troyer, et al.Surgical Oncology Clinics of North America|October 18, 2005
Screening for prostate cancer: opportunities and challengesIan M Thompson, Carlos Bermejo, Javier Hernandez, et al.Urology|August 27, 2010
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screeningYuanyuan Liang, Donna P Ankerst, Michael Sanchez, et al.Journal of the National Cancer Institute|February 26, 2011
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detectionAndrew J Vickers, Cathee Till, Catherine M Tangen, et al.Urologic Oncology|April 15, 2004
Relationship of body mass index and prostate specific antigen in a population-based studyIan M Thompson, Robin Leach, Dean Troyer, et al.Pageof 47